FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986834309> ?p ?o ?g. }

• W1986834309 endingPage "645" @default.
• W1986834309 startingPage "639" @default.
• W1986834309 abstract "Topical steroid treatment can be a powerful alternative to surgery in controlling adenoid hypertrophy and otitis media with effusion (OME). A prospective, controlled, randomized, clinical study in an academic tertiary care center. A total of 122 children (3–15-year-old) on the waiting list for an adenoidectomy and/or ventilation tube placement were enrolled into the study and control groups. The study group (67 patients with adenoid hypertrophy, 34 of them with otitis media with effusion) received intranasal mometasone furoate monohydrate 100 mcg/day, and the control group (55 patients with adenoid hypertrophy, 29 of them with otitis media with effusion) was followed up without any treatment. All patients were evaluated at 0 and 6 weeks. The assessment of each patient included history, a symptom questionnaire, a skin prick test, a tympanogram, if possible a pure tone audiogram, and otoscopic and endoscopic examinations. The size of adenoid tissue was graded as a percentage according to obliteration of the choanae. The adenoid/choana ratio (A/C) was recorded for each patient. Symptoms were scored as 0 (absent), 1 (intermittent/periodic), or 2 (continuous). The data were analyzed with the “Statistical Package for the Social Sciences” (SPSS 9.0) using the appropriate nonparametric tests for nominal and ordinal data. Resolution of otitis media with effusion in the study group (42.2%) was significantly higher than that in the control group (14.5%) (p < 0.001). Forty-five patients (67.2%) with adenoid hypertrophy in the study group showed a significant decrease in adenoid size according to the endoscopic evaluation compared to the control group (p < 0.001). A significant improvement in obstructive symptoms was seen in the study group (p < 0.001). The endoscopically measured adenoid/choana ratio and degree of obstructive symptoms showed a significant correlation (r = 0.838 p < 0.001, r = 0.879 p < 0.001, r = 0.838 p < 0.001, r = 0.879 p < 0.001). The adenoid/choana ratio improved significantly in atopic patients in the study group (p < 0.05), whereas in atopic patients in the control group there was no change (p = 0.221). Nasal mometasone furoate monohydrate treatment can significantly reduce adenoid hypertrophy and eliminate obstructive symptoms. It is a useful alternative to surgery, at least in the short term, for otitis media with effusion." @default.
• W1986834309 created "2016-06-24" @default.
• W1986834309 creator A5017856162 @default.
• W1986834309 creator A5054833003 @default.
• W1986834309 date "2006-04-01" @default.
• W1986834309 modified "2023-10-09" @default.
• W1986834309 title "The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy" @default.
• W1986834309 cites W1505741973 @default.
• W1986834309 cites W1759080189 @default.
• W1986834309 cites W1941620283 @default.
• W1986834309 cites W1968329852 @default.
• W1986834309 cites W1970124329 @default.
• W1986834309 cites W1971316257 @default.
• W1986834309 cites W1973651599 @default.
• W1986834309 cites W1976873708 @default.
• W1986834309 cites W1989060196 @default.
• W1986834309 cites W1996808836 @default.
• W1986834309 cites W2009171069 @default.
• W1986834309 cites W2013085518 @default.
• W1986834309 cites W2016764529 @default.
• W1986834309 cites W2030517083 @default.
• W1986834309 cites W2047707249 @default.
• W1986834309 cites W2066713076 @default.
• W1986834309 cites W2067526776 @default.
• W1986834309 cites W2076992080 @default.
• W1986834309 cites W2078300418 @default.
• W1986834309 cites W2098343405 @default.
• W1986834309 cites W2100025743 @default.
• W1986834309 cites W2125547264 @default.
• W1986834309 cites W2159189010 @default.
• W1986834309 cites W2292346923 @default.
• W1986834309 cites W2415357849 @default.
• W1986834309 cites W2571244510 @default.
• W1986834309 cites W4255773272 @default.
• W1986834309 doi "https://doi.org/10.1016/j.ijporl.2005.08.013" @default.
• W1986834309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16169093" @default.
• W1986834309 hasPublicationYear "2006" @default.
• W1986834309 type Work @default.
• W1986834309 sameAs 1986834309 @default.
• W1986834309 citedByCount "105" @default.
• W1986834309 countsByYear W19868343092012 @default.
• W1986834309 countsByYear W19868343092013 @default.
• W1986834309 countsByYear W19868343092014 @default.
• W1986834309 countsByYear W19868343092015 @default.
• W1986834309 countsByYear W19868343092016 @default.
• W1986834309 countsByYear W19868343092017 @default.
• W1986834309 countsByYear W19868343092018 @default.
• W1986834309 countsByYear W19868343092019 @default.
• W1986834309 countsByYear W19868343092020 @default.
• W1986834309 countsByYear W19868343092021 @default.
• W1986834309 countsByYear W19868343092022 @default.
• W1986834309 countsByYear W19868343092023 @default.
• W1986834309 crossrefType "journal-article" @default.
• W1986834309 hasAuthorship W1986834309A5017856162 @default.
• W1986834309 hasAuthorship W1986834309A5054833003 @default.
• W1986834309 hasConcept C126322002 @default.
• W1986834309 hasConcept C141071460 @default.
• W1986834309 hasConcept C163430725 @default.
• W1986834309 hasConcept C167414201 @default.
• W1986834309 hasConcept C2776008533 @default.
• W1986834309 hasConcept C2776439223 @default.
• W1986834309 hasConcept C2776804153 @default.
• W1986834309 hasConcept C2777346780 @default.
• W1986834309 hasConcept C2779073326 @default.
• W1986834309 hasConcept C2781163425 @default.
• W1986834309 hasConcept C2781348165 @default.
• W1986834309 hasConcept C71924100 @default.
• W1986834309 hasConceptScore W1986834309C126322002 @default.
• W1986834309 hasConceptScore W1986834309C141071460 @default.
• W1986834309 hasConceptScore W1986834309C163430725 @default.
• W1986834309 hasConceptScore W1986834309C167414201 @default.
• W1986834309 hasConceptScore W1986834309C2776008533 @default.
• W1986834309 hasConceptScore W1986834309C2776439223 @default.
• W1986834309 hasConceptScore W1986834309C2776804153 @default.
• W1986834309 hasConceptScore W1986834309C2777346780 @default.
• W1986834309 hasConceptScore W1986834309C2779073326 @default.
• W1986834309 hasConceptScore W1986834309C2781163425 @default.
• W1986834309 hasConceptScore W1986834309C2781348165 @default.
• W1986834309 hasConceptScore W1986834309C71924100 @default.
• W1986834309 hasIssue "4" @default.
• W1986834309 hasLocation W19868343091 @default.
• W1986834309 hasLocation W19868343092 @default.
• W1986834309 hasOpenAccess W1986834309 @default.
• W1986834309 hasPrimaryLocation W19868343091 @default.
• W1986834309 hasRelatedWork W1962792472 @default.
• W1986834309 hasRelatedWork W2085165922 @default.
• W1986834309 hasRelatedWork W2085709202 @default.
• W1986834309 hasRelatedWork W2102818983 @default.
• W1986834309 hasRelatedWork W2316018541 @default.
• W1986834309 hasRelatedWork W2357674314 @default.
• W1986834309 hasRelatedWork W2377995846 @default.
• W1986834309 hasRelatedWork W2440260067 @default.
• W1986834309 hasRelatedWork W2601863198 @default.
• W1986834309 hasRelatedWork W3130837726 @default.
• W1986834309 hasVolume "70" @default.
• W1986834309 isParatext "false" @default.
• W1986834309 isRetracted "false" @default.
• W1986834309 magId "1986834309" @default.

• next